FDAFDA · Food and drugs·Recall number D-0149-2024
Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Valles, Spain, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, N.J. 07936, NDC 0078-1077-66
Published December 20, 2023 · Recall initiated: November 20, 2023
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated
Recall details
- Brand
- VOTRIENT
- Manufacturer
- Siegfried Barbera, SL
- Distributor
- Nationwide
- Lot
- Lot# ME2713; Exp. 02/2025 Lot # MF8286, ML1860; Exp. 04/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Spain
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.